Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > This is a gift
View:
Post by 2019champs on Jul 16, 2021 1:42pm

This is a gift

The problem is over the years, the tsx has had a lot of crappy penny stocks. Pump and dumps, bankrupt stocks, crappy unhonest ceo's, the weed sector which was many investors lost a sh*t ton on, etc. People just think arch is just another one of those, and we smart long investors who have done our research know that's not the case here. Metablok, if it works is a billion dollar drug minimum in my opinion. Oh, and you still have the rest of the pipeline. Wait until the reddit guys find out about this. Some pharma company is going to want in on this too. Fun times
Comment by Riverfolk on Jul 16, 2021 2:18pm
I agree with you 100%, this technology if safe in humans and proven to have efficacy will have tremendous upside from here. Upside would change depending on Lung, Liver or Kidney.  current market cap $62,000,000 US My short term target 400,000,000 US  $6.45 US roughly $7 Can  My medium target $12 Can Long Term target $22 Can  Good luck to all   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities